Jaguar Health Inc
JAGX
Get informed when a big investor buys or sells
+ FollowMarket Cap$236.57K
Close$
$-0.98
133.7% downside
Current Fair Value
133.7% downsideOvervalued by 133.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $236,572.00 |
|---|---|
| Enterprise Value | $27.44 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-803.95 |
| Beta | 0.03 |
| Outstanding Shares | 515,788 |
Return
| Return on Equity | 217.51% |
|---|---|
| Return on Assets | -91.53% |
| Return on Invested Capital | 607.35% |
Valuation & Multiples
| P/E Ratio | -0.05 |
|---|---|
| PEG | 0.03 |
| Price to Sales | 0.05 |
| Price to Book Ratio | -0.09 |
| Enterprise Value to Revenue | 0.93 |
| Enterprise Value to EBIT | -1.39 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.26 |
| Debt to Equity | -2.19 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 25, 2026
EPS Estimate
$-149.10
Average shareholder expectationRevenue Estimate
$4.21 M
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-52.15
Average shareholder expectationRevenue Estimate
$4.24 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 10.98%▲ 6.65% |
|---|---|
| Total Invested | $94,198▲ 53.54% |
| Investors Holding | 10▼ 1.00% |
ESG Score
No data
About Jaguar Health Inc
CEO: Lisa Conte